Report Detail
Global Oral Proteins and Peptides Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
- RnM4617171 |
- 26 September, 2024 |
- Global |
- 77 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Polypeptide and protein drugs refer to the biological drugs of polypeptide and protein substances used for prevention,treatment and diagnosis.Polypeptide is a compound formed by linking α-amino acids together with a peptide chain,and it is also an intermediate product of proteolysis.N polypeptide chains are entangled in a certain spatial structure to form a protein.The hydrolysis of macromolecular proteins produces polypeptides.Such drugs are biochemical preparations and have relatively strict requirements on storage and transportation environment.The Oral Proteins and Peptides industry can be broken down into several segments, Linaclotide, Insulin, Plecanatide, Cyclosporine, Octreotide, etc.Across the world, the major players cover Ironwood & Allergan (AbbVie), Novo Nordisk, Synergy Pharmaceuticals (Salix), Novartis, Chiasma (Amryt Pharma), etc.
According to our (Global Info Research) latest study, the global Oral Proteins and Peptides market size was valued at US$ 3054 million in 2023 and is forecast to a readjusted size of USD 7903 million by 2030 with a CAGR of 14.7% during review period.
Ironwood & Allergan is one of the most important global manufacturers of oral proteins and peptides, other key manufacturers include Novo Nordisk. North America is the largest market, occupied for over 60%. In terms of type, insulin is the largest segment, with a share of over 60%. And in terms of application, gastric & digestive disorders and bone diseases segment holds the most share.
This report is a detailed and comprehensive analysis for global Oral Proteins and Peptides market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Oral Proteins and Peptides market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Mg), 2019-2030
Global Oral Proteins and Peptides market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Mg), 2019-2030
Global Oral Proteins and Peptides market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Mg), 2019-2030
Global Oral Proteins and Peptides market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Mg), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oral Proteins and Peptides
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oral Proteins and Peptides market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ironwood & Allergan, Novo Nordisk, Synergy Pharmaceuticals （Salix）, Novartis, Chiasma (Amryt Pharma), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Oral Proteins and Peptides market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Linaclotide
Insulin
Plecanatide
Cyclosporine
Octreotide
Market segment by Application
Gastric & Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders
Major players covered
Ironwood & Allergan
Novo Nordisk
Synergy Pharmaceuticals （Salix）
Novartis
Chiasma (Amryt Pharma)
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Proteins and Peptides product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oral Proteins and Peptides, with price, sales quantity, revenue, and global market share of Oral Proteins and Peptides from 2019 to 2024.
Chapter 3, the Oral Proteins and Peptides competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Proteins and Peptides breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Oral Proteins and Peptides market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Proteins and Peptides.
Chapter 14 and 15, to describe Oral Proteins and Peptides sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Oral Proteins and Peptides Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Linaclotide
- 1.3.3 Insulin
- 1.3.4 Plecanatide
- 1.3.5 Cyclosporine
- 1.3.6 Octreotide
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Oral Proteins and Peptides Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Gastric & Digestive Disorders
- 1.4.3 Bone Diseases
- 1.4.4 Diabetes
- 1.4.5 Hormonal Disorders
- 1.5 Global Oral Proteins and Peptides Market Size & Forecast
- 1.5.1 Global Oral Proteins and Peptides Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global Oral Proteins and Peptides Sales Quantity (2019-2030)
- 1.5.3 Global Oral Proteins and Peptides Average Price (2019-2030)
2 Manufacturers Profiles
- 2.1 Ironwood & Allergan
- 2.1.1 Ironwood & Allergan Details
- 2.1.2 Ironwood & Allergan Major Business
- 2.1.3 Ironwood & Allergan Oral Proteins and Peptides Product and Services
- 2.1.4 Ironwood & Allergan Oral Proteins and Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Ironwood & Allergan Recent Developments/Updates
- 2.2 Novo Nordisk
- 2.2.1 Novo Nordisk Details
- 2.2.2 Novo Nordisk Major Business
- 2.2.3 Novo Nordisk Oral Proteins and Peptides Product and Services
- 2.2.4 Novo Nordisk Oral Proteins and Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Novo Nordisk Recent Developments/Updates
- 2.3 Synergy Pharmaceuticals （Salix）
- 2.3.1 Synergy Pharmaceuticals （Salix） Details
- 2.3.2 Synergy Pharmaceuticals （Salix） Major Business
- 2.3.3 Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Product and Services
- 2.3.4 Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Synergy Pharmaceuticals （Salix） Recent Developments/Updates
- 2.4 Novartis
- 2.4.1 Novartis Details
- 2.4.2 Novartis Major Business
- 2.4.3 Novartis Oral Proteins and Peptides Product and Services
- 2.4.4 Novartis Oral Proteins and Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Novartis Recent Developments/Updates
- 2.5 Chiasma (Amryt Pharma)
- 2.5.1 Chiasma (Amryt Pharma) Details
- 2.5.2 Chiasma (Amryt Pharma) Major Business
- 2.5.3 Chiasma (Amryt Pharma) Oral Proteins and Peptides Product and Services
- 2.5.4 Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Chiasma (Amryt Pharma) Recent Developments/Updates
3 Competitive Environment: Oral Proteins and Peptides by Manufacturer
- 3.1 Global Oral Proteins and Peptides Sales Quantity by Manufacturer (2019-2024)
- 3.2 Global Oral Proteins and Peptides Revenue by Manufacturer (2019-2024)
- 3.3 Global Oral Proteins and Peptides Average Price by Manufacturer (2019-2024)
- 3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of Oral Proteins and Peptides by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 Oral Proteins and Peptides Manufacturer Market Share in 2023
- 3.4.3 Top 6 Oral Proteins and Peptides Manufacturer Market Share in 2023
- 3.5 Oral Proteins and Peptides Market: Overall Company Footprint Analysis
- 3.5.1 Oral Proteins and Peptides Market: Region Footprint
- 3.5.2 Oral Proteins and Peptides Market: Company Product Type Footprint
- 3.5.3 Oral Proteins and Peptides Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Oral Proteins and Peptides Market Size by Region
- 4.1.1 Global Oral Proteins and Peptides Sales Quantity by Region (2019-2030)
- 4.1.2 Global Oral Proteins and Peptides Consumption Value by Region (2019-2030)
- 4.1.3 Global Oral Proteins and Peptides Average Price by Region (2019-2030)
- 4.2 North America Oral Proteins and Peptides Consumption Value (2019-2030)
- 4.3 Europe Oral Proteins and Peptides Consumption Value (2019-2030)
- 4.4 Asia-Pacific Oral Proteins and Peptides Consumption Value (2019-2030)
- 4.5 South America Oral Proteins and Peptides Consumption Value (2019-2030)
- 4.6 Middle East & Africa Oral Proteins and Peptides Consumption Value (2019-2030)
5 Market Segment by Type
- 5.1 Global Oral Proteins and Peptides Sales Quantity by Type (2019-2030)
- 5.2 Global Oral Proteins and Peptides Consumption Value by Type (2019-2030)
- 5.3 Global Oral Proteins and Peptides Average Price by Type (2019-2030)
6 Market Segment by Application
- 6.1 Global Oral Proteins and Peptides Sales Quantity by Application (2019-2030)
- 6.2 Global Oral Proteins and Peptides Consumption Value by Application (2019-2030)
- 6.3 Global Oral Proteins and Peptides Average Price by Application (2019-2030)
7 North America
- 7.1 North America Oral Proteins and Peptides Sales Quantity by Type (2019-2030)
- 7.2 North America Oral Proteins and Peptides Sales Quantity by Application (2019-2030)
- 7.3 North America Oral Proteins and Peptides Market Size by Country
- 7.3.1 North America Oral Proteins and Peptides Sales Quantity by Country (2019-2030)
- 7.3.2 North America Oral Proteins and Peptides Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
- 8.1 Europe Oral Proteins and Peptides Sales Quantity by Type (2019-2030)
- 8.2 Europe Oral Proteins and Peptides Sales Quantity by Application (2019-2030)
- 8.3 Europe Oral Proteins and Peptides Market Size by Country
- 8.3.1 Europe Oral Proteins and Peptides Sales Quantity by Country (2019-2030)
- 8.3.2 Europe Oral Proteins and Peptides Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
- 9.1 Asia-Pacific Oral Proteins and Peptides Sales Quantity by Type (2019-2030)
- 9.2 Asia-Pacific Oral Proteins and Peptides Sales Quantity by Application (2019-2030)
- 9.3 Asia-Pacific Oral Proteins and Peptides Market Size by Region
- 9.3.1 Asia-Pacific Oral Proteins and Peptides Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific Oral Proteins and Peptides Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 South Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
- 10.1 South America Oral Proteins and Peptides Sales Quantity by Type (2019-2030)
- 10.2 South America Oral Proteins and Peptides Sales Quantity by Application (2019-2030)
- 10.3 South America Oral Proteins and Peptides Market Size by Country
- 10.3.1 South America Oral Proteins and Peptides Sales Quantity by Country (2019-2030)
- 10.3.2 South America Oral Proteins and Peptides Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
- 11.1 Middle East & Africa Oral Proteins and Peptides Sales Quantity by Type (2019-2030)
- 11.2 Middle East & Africa Oral Proteins and Peptides Sales Quantity by Application (2019-2030)
- 11.3 Middle East & Africa Oral Proteins and Peptides Market Size by Country
- 11.3.1 Middle East & Africa Oral Proteins and Peptides Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa Oral Proteins and Peptides Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
- 12.1 Oral Proteins and Peptides Market Drivers
- 12.2 Oral Proteins and Peptides Market Restraints
- 12.3 Oral Proteins and Peptides Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Oral Proteins and Peptides and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Oral Proteins and Peptides
- 13.3 Oral Proteins and Peptides Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Oral Proteins and Peptides Typical Distributors
- 14.3 Oral Proteins and Peptides Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Oral Proteins and Peptides. Industry analysis & Market Report on Oral Proteins and Peptides is a syndicated market report, published as Global Oral Proteins and Peptides Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Oral Proteins and Peptides market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
